MEM INST OSWALDO CRUZ, RIO DE JANEIRO, 112(4) April 2017
PAGES: 237-246 DOI: 10.1590/0074-02760160173 Full paper
Evaluation of the impact of serogroup C meningococcal disease vaccination program in Brazil and its regions: a population-based study, 2001-2013

Camile de Moraes1,2,+, José Cássio de Moraes3, Gabriela Drummond Marques da Silva4, Elisabeth Carmen Duarte1

1Universidade de Brasília, Faculdade de Medicina, Programa de Pós-Graduação em Medicina Tropical, Brasília, DF, Brasil
2Ministério da Saúde, Secretaria de Vigilância em Saúde, Brasília, DF, Brasil
3Faculdade de Ciências Médicas da Santa Casa, São Paulo, SP, Brasil
4Universidade de Brasília, Faculdade de Ciências da Saúde, Programa de Pós-Graduação em Saúde Coletiva, Brasília, DF, Brasil

Abstract

BACKGROUND Meningococcal C conjugate (MenC) vaccine was introduced as part of the Brazilian National Immunisation Program in 2010 for children < 1 year of age.

OBJECTIVES The study objective was to evaluate the impact of this vaccination strategy.

METHODS An observational, mixed ecological and analytical study was conducted, based on time series panel data from surveillance records (2001-2013).

FINDINGS A total of 37,538 of meningococcal disease cases were recorded during the study period. Of these, 19,997 were attributed to serogroup C. A decrease in meningococcal disease serogroup C (MDC) incidence among children aged 1 year [65.2%; 95% confidence interval (CI): 20.5-84.7%] and 1-4 years (46.9%; 95%CI: 14.6-79.1%) were found in the three years following vaccination introduction. Vaccination impact on the reduction of MDC incidence varied from83.7% (95%CI: 51.1-100.0%) in the Midwest region to 56.7% (95%CI: 37.4-76.0%) in the Northeast region.

MAIN CONCLUSIONS Vaccination against MDC in Brazil had a positive impact on the population of children aged 1 year, across all regions, and on the 1-4 year-old cohort. Nevertheless, in our view there is scope for iproving the vaccination strategy adopted in Brazil.

+ Corresponding author: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Received 26 April 2016
Accepted 15 December 2016

CONTACT US

Memórias do Instituto Oswaldo Cruz

Av. Brasil 4365, Castelo Mourisco
sala 201, Manguinhos, 21040-900
Rio de Janeiro, RJ, Brazil

Tel.: +55-21-2562-1222

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

twitterfacebook

SUPPORT PROGRAM

marca fiocruzmarca brasil
marca faperjmarca cnpqmarca capes n